(6α)-21-(Acetyloxy)-6-fluoropregna-1,4,9(11),16-tetraene-3,20-dione
|
- $900
- Product name: (6α)-21-(Acetyloxy)-6-fluoropregna-1,4,9(11),16-tetraene-3,20-dione
- CAS: 2476-74-6
- MF: C23H25FO4
- MW: 384.44
- EINECS:
- MDL Number:MFCD31561807
- Synonyms:(6α)-21-(Acetyloxy)-6-fluoropregna-1,4,9(11),16-tetraene-3,20-dione;Pregna-1,4,9(11),16-tetraene-3,20-dione, 21-(acetyloxy)-6-fluoro-, (6α)-;(6alpha)-21-(Acetyloxy)-6-fluoropregna-1,4,9(11),16-tetraene-3,20-dione;(6α)-21-(Acetyloxy)-6-fluoropregna-1,4,9(11),16-tetraene-3,20-dione, CAS 2476-74-6
3 prices
Selected condition：
Brand
- Biosynth
Package
- 25mg
- 50mg
- 100mg
- ManufacturerBiosynth
- Product numberFA99110
- Product description(6alpha)-21-(Acetyloxy)-6-fluoropregna-1,4,9(11),16-tetraene-3,20-dione
- Packaging100mg
- Price$900
- Updated2026-06-04
- Buy
- ManufacturerBiosynth
- Product numberFA99110
- Product description(6alpha)-21-(Acetyloxy)-6-fluoropregna-1,4,9(11),16-tetraene-3,20-dione
- Packaging25mg
- Price$900
- Updated2026-06-04
- Buy
- ManufacturerBiosynth
- Product numberFA99110
- Product description(6alpha)-21-(Acetyloxy)-6-fluoropregna-1,4,9(11),16-tetraene-3,20-dione
- Packaging50mg
- Price$900
- Updated2026-06-04
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Biosynth | FA99110 | (6alpha)-21-(Acetyloxy)-6-fluoropregna-1,4,9(11),16-tetraene-3,20-dione | 100mg | $900 | 2026-06-04 | Buy |
| Biosynth | FA99110 | (6alpha)-21-(Acetyloxy)-6-fluoropregna-1,4,9(11),16-tetraene-3,20-dione | 25mg | $900 | 2026-06-04 | Buy |
| Biosynth | FA99110 | (6alpha)-21-(Acetyloxy)-6-fluoropregna-1,4,9(11),16-tetraene-3,20-dione | 50mg | $900 | 2026-06-04 | Buy |
Properties
Melting point :188-190 °C
Boiling point :536.4±50.0 °C(Predicted)
Density :1.24±0.1 g/cm3(Predicted)
Boiling point :536.4±50.0 °C(Predicted)
Density :1.24±0.1 g/cm3(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|